celastrol has been researched along with glucagon-like peptide 1 in 1 studies
Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
---|---|---|---|---|---|
885 | 1 | 741 | 9,484 | 1,208 | 6,374 |
Protein | Taxonomy | celastrol (IC50) | glucagon-like peptide 1 (IC50) |
---|---|---|---|
Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arreaza-RubĂn, G; Duclos, SK; Grant, CW; Guberski, DL; Moran-Paul, CM; Spain, LM | 1 |
1 other study(ies) available for celastrol and glucagon-like peptide 1
Article | Year |
---|---|
Testing agents for prevention or reversal of type 1 diabetes in rodents.
Topics: Animals; Antibodies; Blood Glucose; CD3 Complex; Diabetes Mellitus, Type 1; Disease Models, Animal; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Pentacyclic Triterpenes; Rats; Remission Induction; Triterpenes | 2013 |